Trial
NCT05691829
Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
NYU Langone Health
Collaborators
—
Condition
NSCLC Stage IV
Intervention
Pembrolizumab
Why stopped
Terminated due to insufficient enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-29